Corvus Pharmaceuticals CRVS Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $4.58M-47.6% | $8.74M-30.7% | $12.62M-4.1% | $13.16M-79.3% | ||
| $52.17M+20.7% | $43.22M— | —— | —— | ||
| $37K-50.7% | $75K+188% | $26K-95.6% | $588K+16.0% | ||
| $58.21M+7.0% | $54.41M+94.6% | $27.96M-36.0% | $43.66M-38.8% | ||
| $220K+45.7% | $151K-36.0% | $236K-33.1% | $353K-21.7% | ||
| $71.12M+3.2% | $68.91M+51.3% | $45.55M-33.2% | $68.24M-37.7% | ||
| $2.49M-3.5% | $2.58M+69.3% | $1.53M-22.8% | $1.98M+26.3% | ||
| $9.38M-73.5% | $35.4M+415% | $6.87M-36.1% | $10.75M+10.9% | ||
| $9.91M-72.7% | $36.34M+429% | $6.87M-43.3% | $12.13M-1.4% | ||
| $7K0.0% | $7K+40.0% | $5K0.0% | $5K0.0% | ||
| -$412.29M-3.8% | -$397.01M-18.6% | -$334.72M-8.8% | -$307.69M-15.5% | ||
| $61.21M+87.9% | $32.57M-15.8% | $38.68M-31.1% | $56.12M-42.2% | ||
| $71.12M+3.2% | $68.91M+51.3% | $45.55M-33.2% | $68.24M-37.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Corvus Pharmaceuticals's total assets?
- Corvus Pharmaceuticals (CRVS) holds $253.2M in total assets, up 326.0% year over year.
- How much debt does Corvus Pharmaceuticals have?
- Corvus Pharmaceuticals carries $834.0K in total debt against $240.7M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does Corvus Pharmaceuticals have?
- Corvus Pharmaceuticals holds $40.1M in cash and equivalents.
- Can Corvus Pharmaceuticals cover its short-term obligations?
- Its current ratio is 19.81 — current assets exceed current liabilities.
- Where does Corvus Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Corvus Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.